Sarepta Therapeutics
SRPT
SRPT
177 hedge funds and large institutions have $1.08B invested in Sarepta Therapeutics in 2016 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 63 increasing their positions, 54 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 50
58% less capital invested
Capital invested by funds: $2.59B → $1.08B (-$1.51B)
64% less funds holding in top 10
Funds holding in top 10: 11 → 4 (-7)
Holders
177
Holding in Top 10
4
Calls
$212M
Puts
$195M
Top Buyers
| 1 | +$60.4M | |
| 2 | +$40.6M | |
| 3 | +$19.1M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$14.7M |
| 5 |
CCM
Cadian Capital Management
New York
|
+$9.57M |
Top Sellers
| 1 | -$52.6M | |
| 2 | -$44.3M | |
| 3 | -$40.5M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$39.3M |
| 5 |
Jennison Associates
New York
|
-$22.8M |